Proceedings of the 15th Antiepileptic Drug and Device Trials Meeting: State of the Science

Christina M Boada, Jacqueline A French, Sonya B Dumanis, Christina M Boada, Jacqueline A French, Sonya B Dumanis

Abstract

On May 22-24, 2019, the 15th Antiepileptic Drug and Device (AEDD) Trials Conference was held, which focused on current issues related to AEDD development from preclinical models to clinical prognostication. The conference featured regulatory agencies, academic laboratories, and healthcare companies involved in emerging epilepsy therapies and research. The program included discussions around funding and support for investigations in epilepsy and neurologic research, clinical trial design and integrated outcome measures for people with epilepsy, and drug development and upcoming disease-modifying therapies. Finally, the conference included updates from the preclinical, clinical, and device pipeline. Summaries of the talks are provided in this paper, with the various pipeline therapeutics in the listed tables to be outlined in a subsequent publication.

Keywords: Devices; Diagnostics; Epilepsy; Seizure; Therapeutics; Therapies.

Conflict of interest statement

Declaration of competing interest There are no conflict of interests to report.

Copyright © 2020 The Authors. Published by Elsevier Inc. All rights reserved.

Source: PubMed

3
Sottoscrivi